Want to learn about Coronary IVL and get CME credits? You're in luck! SCAI is offering a great recorded case and discussion for 1.5 credits featuring an all-star panel of Shockwave IVL experts.
Welcome to The Catalyst
Change isn't quick. Unless it's when you experience Intravascular Lithotripsy (IVL) for the first time. Stay apprised of our latest news and insights while discovering how a simple and intuitive tool can be The Catalyst to change the way you think about calcium modification.
Want to learn about Coronary IVL and get CME credits? You're in luck! SCAI is offering a great recorded case and discussion for 1.5 credits featuring an all-star panel of Shockwave IVL experts.
Topics: Coronary IVL
Blast into the past with the co-founder of IVL technology, John Adams, and Dr. Ziad Ali as they reminisce on what brought Shockwave here today! In ChalkTalk episode three, Adams explains how the “Shockwave spark” idea was conceptualized and how the whole design came to life. They discuss the challenges that were overcome in the technology’s development and reveal exciting breakthrough moments that motivated them to push against all odds. Hear them share deep insights into IVL’s unique Mechanism of Action and their personal experiences using the technology across the globe.
Topics: Coronary IVL, Peripheral IVL, IVL Technology, SWAV News, ChalkTalk Podcast
Topics: Coronary IVL, Shockwave C2, Calcium Corner
In the second episode of ChalkTalk, calcium experts Drs. Ziad Ali (St. Francis Hospital), Robert Riley (The Christ Hospital), Robert Yeh (Beth Israel Deaconess Medical Center), Richard Shlofmitz (St. Francis Hospital), and Philippe Genereux (Morristown Medical Center) discuss the real-world utilization of Coronary IVL since FDA approval in the U.S during a recent webinar broadcast online. They share tips and tricks for adopting the new technology, discuss pulse management strategies, and share insights into how they have pushed the boundaries with the technology in early days. Let’s get cracking!
Topics: Coronary IVL, Peripheral IVL, IVL Technology, SWAV News, ChalkTalk Podcast
Shockwave has been making waves this summer! As you dive into this edition of the PulsePoint Newsletter, you’ll see that JACC: Cardiovascular Interventions published a trilogy of peer-reviewed publications highlighting Shockwave’s MOA, a pooled analysis of the 4 Disrupt CAD studies, and Disrupt PAD lll. Dive deeper and you’ll discover the incredible 10-webinar series called Calcium Masterclass that was launched at the beginning of the quarter. Explore how Shockwave was granted transitional pass-through reimbursement for Coronary IVL and proposed additional payment for hospital in-patient Coronary IVL cases performed in the United States. This PulsePoint has a lot to cover – recap the rest of the events and milestones from an exciting last quarter. But as you relax on your vacation, always stay on the pulse!
Topics: Coronary IVL, Peripheral IVL, IVL Technology, PulsePoint Newsletter
Learn about IVL’s unique mechanism of action in fracturing severe, superficial and deep calcium and the clinical outcomes associated with IVL in the coronary and peripheral vasculature.
Topics: IVL Technology, Coronary Clinical Data, Peripheral Clinical Data
Topics: IVL Technology, Coronary Clinical Data, Peripheral Clinical Data
Treatment of nodular calcium in coronary PCI remains a challenge, even for the most skilled operators. Recently, CRT 2021 Virtual featured a live case from Medstar Washington Hospital Center in Washington, DC with nodular calcium from operators Hayder D. Hashim, MD, and Lowell F. Satler, MD, who were joined by an expert panel led by Ron Waksman, MD. During the case the physicians discussed and debated treatment strategies to address nodular calcium, deciding in this case for coronary IVL, which resulted from a baseline MLA of 1.6mm2 to a post-IVL MLA of 4.9mm2 to a post-DES MSA of 7.2mm2.
Topics: Coronary IVL, Shockwave C2
If you missed the two Shockwave IVL sessions at EuroPCR 2021, or would like to watch the symposia again, you’re in luck. The Shockwave IVL content from EuroPCR 2021 is available here.
Topics: Coronary Clinical Data, Shockwave C2, Coronary Conferences
PulsePoint is back! Bringing you a highlight reel of the most memorable moments, successes and key events of Q1 for both our coronary and peripheral technology. Most notably, Shockwave had a history-making moment in February of this year when we received FDA approval in the U.S. for Coronary IVL! Since then, we have seen many physicians achieving great success utilizing the technology. We also brought a new podcast, ChalkTalk, to life, and so much more we want to share with you. Check out the latest PulsePoint for the full scoop!
Topics: Coronary IVL, Peripheral IVL, IVL Technology, PulsePoint Newsletter